Cytokine expression in human cutaneous chronic graft-versus-host disease

Bone Marrow Transplantation

Volumn 17, Issue 6, 1996, Pages 1085-1092

  Ochs, L A ^a,c   Blazar, B R ^a   Roy, J ^a,d   Rest, E B ^a   Weisdorf, D J ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIV OF MINNESOTA HOSP AND CLINIC   (United States)

^c Riverside Group Health   (United States)

^d LAVAL UNIVERSITY   (Canada)

Author keywords

Chronic graft versus host disease; Cytokines; Polymerase chain reaction; Skin

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC TRANSCRIPTION; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN TISSUE; MALE; PATHOGENESIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN BIOPSY;

ADULT; CHILD; CYTOKINES; FEMALE; GRAFT VS HOST DISEASE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-2; MALE; MIDDLE AGED; RNA, MESSENGER; SKIN DISEASES;

EID: 0030018735     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Vogelsang GB, Hess AD. Graft-versus-host disease: new directions for a persistent problem. Blood 1994; 84: 2061-2067.
2. Cohen J. Cytokines as mediators of graft-versus-host disease. Bone Marrow Transplant 1988; 3: 193-197.
3. Jadus MR, Wepsic HT. The role of cytokines in graft-versus-host reactions and disease. Bone Marrow Transplant 1992; 10: 1-14.
4. Ferrar JL. Cytokines other than growth factors in bone marrow transplantation. Curr Opin Oncol 1994; 6: 127-134.
5. Antin JH, Ferrara JLM. Cytokine dysregulation and acute graft-versus-host disease. Blood 1992; 12: 2964-2968.
6. Mosmann TR, Cherwinski H, Bond MW et al. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986; 136: 2348-2357.
7. Salgame P, Abrams JS, Clayberger C et al. Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science 1991; 254: 279-282.
8. Cherwinski H, Schumacher JH, Brown KD, Mosmann TR. Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies. J Exp Med 1987; 166: 1229-1244.
9. Gajewski TF, Fitch FW. Anti-proliferative effect of IFN-γ in immune regulation. I. IFN-γ inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones. J Immunol 1988; 140: 4245-4252.
10. Fiorentino DF, Bond MW, Mosmann TR. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989; 170: 2081-2095.
11. Chomzynski P, Sacchi N. Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
12. Yamamura M, Uyemura K, Deans RJ et al. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 1991; 254: 277-279.
13. Roy J, Blazar BR, Ochs L, Weisdorf DJ. The tissue expression of cytokines in human acute cutaneous graft-versus-host disease. Transplantation 1995; 60: 343-348.
14. Kaashoek JGJ, Mout R, Falkenburg JHF et al. Cytokine production by the bladder carcinoma cell line 5637: rapid analysis of mRNA expression levels using a cDNA-PCR procedure. Lymphokine Cytokine Res 1991; 10: 231-235.
15. Kennedy MJ, Vogelsang GB, Jones RJ et al. Phase 1 trial of interferon gamma to potentiate cyclosporine-induced graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer. J Clin Oncol 1994; 12: 249-257.
16. Dickinson AM, Sviland L, Dunn J et al. Demonstration of direct involvement of cytokines in graft-versus-host reaction using an in vitro human skin explant model. Bone Marrow Transplant 1991; 7: 209-216.
17. Dickinson AM, Sviland L, Hamilton PJ et al. Cytokine involvement in predicting clinical graft-versus-host disease in allogeneic bone marrow transplant recipients. Bone Marrow Transplant 1994; 13: 65-70.
18. Mowat A. Antibodies to IFN-gamma prevent immunological mediated intestinal damage to murine graft-versus-host reactions. Immunology 1989; 68: 18-24.
19. Troutt AB, Kelso A. Enumeration of lymphokine mRNA-containing cells in vivo in a murine graft-versus-host reaction using the PCR. Proc Natl Acad Sci USA 1992; 89: 5276-5280.
20. Niederwieser D, Herold M, Woloszczuk W et al. Endogenous IFN-gamma during human bone marrow transplantation. Transplantation 1990; 50: 620-625.
21. Brok HPM, Heidt PJ, van der Meide PH et al. Interferon-γ prevents graft-versus-host disease after allogeneic bone marrow transplantation in mice. J Immunol 1993; 151: 6451-6459.
22. Klimpel GR, Annable CR, Cleveland MG et al. Immunosuppression and lymphoid hypoplasia associated with chronic graft-versus-host disease is dependent upon IFN-γ production. J Immunol 1990; 144: 84-93.
23. Holda JH, Maier T, Claman HN. Evidence that IFN-γ is responsible for natural suppressor activity in GVHD spleen and normal bone marrow. Transplantation 1988; 45: 772-777.
24. Holda JH, Maier T, Claman HN. Natural suppressor activity in graft-versus-host spleen and normal bone marrow is augmented by IL-2 and interferon-γ. J Immunol 1986; 137: 3538-3543.
25. Griffiths CEM, Voorhees JJ, Nickoloff BJ. Gamma interferon induces different keratinocyte cellular patterns of expression of HLA-DR and DQ and intercellular adhesion molecule-1 (ICAM-1) antigens. Br J Dermatol 1989; 120: 1-7.
26. + lymphoid engraftment. J Immunol 1994; 152: 1004-1013.
27. Fowler DH, Kurasawa K, Smith R et al. Donor CD-4 enriched cells of Th2 cytokine phenotype regulate graft-versus-host disease without impairing allogeneic engraftment in sublethally irradiated mice. Blood 1994; 84: 3540-3549.
28. De Wit D, van Mechelen M, Zanin C et al. Preferential activiation of Th2 cells in chronic graft-versus-host reaction. J Immunol 1993; 150: 361-366.
29. Allen RD, Staley TA, Sidman CL. Differential cytokine expression in acute and chronic murine graft-versus-host disease. Ear J Immunol 1993; 23: 333-337.
30. Garlisi CG, Pennline KJ, Smith SR et al. Cytokine gene expression in mice undergoing chronic graft-versus-host disease. Mol Immunol 1993; 30: 669-677.
31. Mustoe TA, Pierce GF, Thomason A et al. Accelerated healing of incisional wounds in rats induced by transforming growth factor-β. Science 1987; 237: 1333-1336.
32. Lynch SE, Colvin RB, Antoniades HN. Growth factors in wound healing: single and synergistic effect on partial thickness porcine skin wounds. J Clin Invest 1989; 84: 640-646.
33. Libby P, Friedman GB, Salomon RN. Cytokines as modulators of cell proliferation in fibrotic diseases. Am Rev Respir Dis 1989; 140: 1114-1117.
34. Freundlich B, Bomalaski JS, Neilson E, Jimenez SA. Regulation of fibroblast proliferation and collagen synthesis by cytokines. Immunol Today 1986; 7: 303-307.
35. Kovacs EJ. Fibrogenic cytokines: the role of immune mediators in the development of scar tissue. Immunol Today 1991; 12: 17-23.
36. Czaja MJ, Weiner FR, Flanders KC et al. In vitro and in vivo association of transforming growth factor-β1 with hepatic fibrosis. J Cell Biol 1989; 108: 2477-2482.
37. Raghu G, Masta S, Meyers D, Narayanan AS. Collagen synthesis by normal and fibrotic human lung fibroblasts and the effect of transforming growth factor-β. Am Rev Respir Dis 1989; 140: 95-100.
38. Anscher MS, Peters WP, Reinsenbichler H et al. Transforming growth factor-β as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer. New Engl J Med 1993; 328: 1592-1598.
39. Unemori EN, Amento EP. Connective tissue metabolism including cytokines in scleroderma. Curr Opin Rheumatol 1991; 3: 953-959.
40. Moreland LW, Goldsmith KT, Russell WJ et al. Transforming growth factor-β within fibrotic scleroderma lungs. Am J Med 1992; 93: 628-636.
41. LeRoy EC, Trojanowska MI, Smith EA. Cytokines and human fibrosis. Eur Cytokine Net 1990; 1: 215-219.